Clinical Trial Update: Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for LFD-200 in healthy adults and adults with rheumatoid arthritis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• LFD-200

Snippet

Sponsor: Lifordi Immunotherapeutics, Inc. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: RECRUITING